With healthcare at a key crossroads of policy, technology, and science, Sanofi CEO Paul Hudson shares the Big Pharma’s ...

GSK announced plans to invest $30bn across the US in research and development and supply chain infrastructure over the next five years. This includes a new $1.2bn investment in advanced manufacturing ...

A long-coveted deal to slash US steel and aluminium tariffs to zero has been shelved on the eve of Donald Trump’s state visit ...

Paul Hudson has a blunt view of peers who hand off the execution of their artificial intelligence strategy to their chief ...

Les grandes entreprises ont été très généreuses avec leurs dirigeants cette année. Aux Etats-Unis, au Royaume-Uni, en Suisse, ...

Rabat — Multinational pharmaceutical and healthcare company Sanofi has announced the appointment of Rami Mroueh as chairman ...

Sanofi ( NASDAQ: SNY) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 1:05 PM EDT ...

Data from the late-stage trial of amlitelimab weren’t as strong as the results seen in Phase 2, adding to doubts about a drug ...

NEW YORK (AP) — Paul Colford, an inexhaustibly curious journalist and author who covered the media business for decades before seeing it from another vantage point as The Associated Press’ chief ...

Paul Colford, an inexhaustibly curious journalist and author who covered the media business for decades before becoming The Associated Press’ chief spokesperson, has died NEW YORK -- Paul Colford, an ...

Sanofi’s amlitelimab met trial endpoints but lagged Dupixent and rivals in strength. Shares fell as investors doubted its potential as a true Dupixent successor. See the trading strategy with a ...

Sanofi shares plunged after its experimental drug for the skin condition atopic dermatitis disappointed investors with a less-than-expected benefit in a late-stage trial.After 24 weeks of treatment, ...